May 21, 2021
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Division of Corporation Finance
Office of Life Sciences
Washington, DC 20549
Attention: |
| Laura Crotty Tim Buchmiller |
|
|
|
Re: |
| Chemesis International Inc. Request for Withdrawal of Offering Statement on Form 1-A Filed May 19, 2020 File No. 024-11217 |
Dear Ms. Crotty and Mr. Buchmiller:
Pursuant to Rule 259 under the Securities Act of 1933, as amended (the “Act”), Chemesis International Inc. (the “Corporation”) hereby requests that the Securities and Exchange Commission consent to the withdrawal of the above referenced offering statement (the “Offering Statement”). Due to the costs associated with meeting regulatory requirements, the Corporation has decided not to pursue a Regulation A exempt offering at this time.
As of this date, the offering has not yet been qualified and none of the securities subject to the Offering Statement have been sold. Additionally, the Offering Statement is not the subject of a suspension of exemption proceeding under Rule 258 of the Act.
Accordingly, we hereby request that the Commission consent to the withdrawal of the Offering Statement with an order granting the withdrawal as of the date of the filing for this request. Should the staff of the Commission have further questions regarding this request, please contact the Corporation’s counsel, Rebecca G. DiStefano, Esq. of Greenberg Traurig, P.A., at (954) 768-8221, or the undersigned at (778) 953-4191. Please provide the undersigned and the Corporation’s counsel with a copy of the order granting withdrawal of the Offering Statement as soon as it is available.
| Very truly yours, |
|
|
|
|
| /s/ Eli Dusenbury |
|
| Eli Dusenbury, Chief Financial Officer |
|
cc: | Ms. Rebecca DiStefano |
| Mr. Deepak Gill |
